Cytori to Present at the 9th Annual LD Micro Main Event Conference on December 6th, 2016
December 05 2016 - 4:05PM
Cytori Therapeutics, Inc. (NASDAQ:CYTX), a late stage cell
therapy company developing autologous cell therapies from adipose
tissue to treat a variety of medical conditions, announced today
that management will present at the 9th Annual LD Micro Main Event
Conference. The Presentation will take place on Tuesday, December
6, 2016 at 12:00PM PST, in Track 4 at the Luxe Sunset Hotel in Los
Angeles, CA.
Management will be available on Tuesday, December 6 and
Wednesday, December 7, 2016 for one-on-one meetings. To schedule a
meeting or for more information, please contact ir@cytori.com.
About LD Micro
The LD Micro Main Event is the largest independent conference
for small/microcap companies and will feature 240 presenting names.
LD Micro was founded in 2006 with the sole purpose of being an
independent resource in the microcap space. What started out as a
newsletter highlighting unique companies has transformed into an
event platform hosting several influential conferences annually
(Invitational, Summit, and Main Event). In 2015, LDM launched the
first pure microcap index (LDMi) to exclusively provide intraday
information on the entire sector.
About Cytori Therapeutics
Cytori Therapeutics is a late stage cell therapy company
developing autologous cell therapies from adipose tissue to treat a
variety of medical conditions. Data from preclinical studies and
clinical trials suggest that Cytori Cell Therapy™ acts principally
by improving blood flow, modulating the immune system, and
facilitating wound repair. As a result, Cytori Cell Therapy™ may
provide benefits across multiple disease states and can be made
available to the physician and patient at the point-of-care through
Cytori’s proprietary technologies and products. For more
information: visit www.cytori.com.
Cytori Therapeutics, Inc.
Tiago Girao, +1 (858) 458.0900
ir@cytori.com
Cytori Therapeutics (NASDAQ:CYTX)
Historical Stock Chart
From Mar 2024 to Apr 2024
Cytori Therapeutics (NASDAQ:CYTX)
Historical Stock Chart
From Apr 2023 to Apr 2024